INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

4,771 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined tomatoes. Clear

10 studies

2013 / Meta-analysis of prospective studies

Tomato and lycopene consumption showed nonsignificant trends toward lower prostate cancer risk.

A meta-analysis evaluated 11 cohort and six nested case-control studies examining tomato and lycopene intake and prostate cancer risk. Higher intake of raw tomatoes (OR = 0.81; 95% CI, 0.59-1.10) and cooked tomatoes (OR = 0.85; 95% CI, 0.69-1.06) was not significantly associated with prostate cancer incidence compared to lower intake. Similarly, higher lycopene intake (OR = 0.93; 95% CI, 0.86-1.01) and serum lycopene (OR = 0.97; 95% CI, 0.88-1.08) showed no statistically significant associations.

Shows an association, not proof of cause and effect.

Chen J, Song Y, Zhang L J Nutr Sci Vitaminol (Tokyo), 2013. PMID 23883692

2015 / Randomized controlled trial

High-dose lycopene, selenium, and green tea catechins showed adverse trends in prostate lesions.

Sixty men with premalignant prostate lesions received daily lycopene (35 mg), selenium (55 µg), and green tea catechins (600 mg), or placebo for 6 months. At re-biopsy in 53 men, prostate cancer was diagnosed in 10 men in the supplement group versus 3 in the placebo group (p = 0.053). Supplementation was also associated with altered microRNA expression linked to cancer progression, while PSA levels and symptom scores showed no significant differences.

Gontero P, Marra G, Soria F, et al. Prostate, 2015. PMID 25893930

2010 / Randomized crossover and parallel trial

Tomato paste and purified lycopene modified gene expression in prostate cancer cells.

In a trial of 30 healthy men aged 50-70 years, participants consumed yellow or red tomato paste (200 g/day) in a crossover design, followed by 16 mg/day purified lycopene or placebo in a parallel phase. Serum from red tomato paste consumption up-regulated IGFBP-3 and the Bax:Bcl-2 ratio while down-regulating cyclin-D1, p53, and Nrf-2 in prostate cancer cells. Purified lycopene up-regulated IGFBP-3, c-fos, and uPAR compared with placebo.

Talvas J, Caris-Veyrat C, Guy L, et al. Am J Clin Nutr, 2010. PMID 20392890

2002 / Nonrandomized single-arm intervention trial

Tomato sauce consumption increased prostate lycopene and reduced DNA damage biomarkers and PSA in men with prostate cancer.

Thirty-two patients with localized prostate adenocarcinoma consumed tomato sauce-based pasta dishes providing 30 mg lycopene daily for 3 weeks before radical prostatectomy. Serum and prostate lycopene increased 1.97- and 2.92-fold, respectively (P < 0.001), while mean serum PSA decreased by 17.5% (P < 0.002) and leukocyte 8OHdG decreased by 21.3% (P < 0.005). Resected tissues showed 28.3% lower prostate 8OHdG than controls (P < 0.03), and cancer cell 8OHdG staining was reduced by 40.5% in mean nuclear density and 36.4% in mean area compared to baseline biopsy.

Bowen P, Chen L, Stacewicz-Sapuntzakis M, et al. Exp Biol Med (Maywood), 2002. PMID 12424330

2001 / Interventional study (pre-post with comparison group)

Tomato sauce consumption increased lycopene levels and reduced oxidative DNA damage and serum PSA in prostate cancer patients.

Thirty-two patients with localized prostate cancer consumed tomato sauce-based pasta dishes (30 mg lycopene/day) for 3 weeks prior to prostatectomy. Following the intervention, serum lycopene significantly rose from 638 to 1258 nM and prostate lycopene increased from 0.28 to 0.82 nmol/g (both P<.001). Leukocyte oxidative DNA damage decreased from 0.61 to 0.48 8-OHdG/10^5 dG (P=.005), and prostate tissue oxidative DNA damage was significantly lower in participants compared to 7 randomly selected patients (0.76 vs. 1.06 8-OHdG/10^5 dG, P=.03). Serum PSA levels dropped significantly from 10.9 ng/mL to 8.7 ng/mL (P<.001).

Chen L, Stacewicz-Sapuntzakis M, Duncan C, et al. J Natl Cancer Inst, 2001. PMID 11752012

2012 / Dietary risk assessment / cross-sectional analysis

In a California risk assessment, all evaluated children exceeded cancer benchmarks for arsenic, dieldrin, DDE, and dioxins.

Researchers estimated exposure to 11 food contaminants using self-reported food frequency data and databases like the Total Diet Study across four age groups. All children (100%) exceeded cancer benchmark levels for arsenic, dieldrin, DDE, and dioxins. Over 95% of preschool-age children exceeded non-cancer benchmarks for acrylamide, and 10% exceeded them for mercury. The greatest exposure to pesticides came from foods including tomatoes, peaches, apples, peppers, grapes, lettuce, broccoli, strawberries, spinach, dairy, pears, green beans, and celery.

Shows an association, not proof of cause and effect.

Vogt R, Bennett D, Cassady D, et al. Environ Health, 2012. PMID 23140444

1995 / Prospective cohort study

Higher intake of lycopene and tomato-based foods was linked to a lower risk of prostate cancer in men.

In the Health Professionals Follow-up Study, dietary intake among 47,894 men was tracked from 1986 to 1992, during which 812 new prostate cancer cases occurred. Intakes of beta-carotene, alpha-carotene, lutein, beta-cryptoxanthin, and retinol were not consistently linked to risk, but lycopene intake was associated with lower risk (RR = 0.79; 95% CI, 0.64-0.99 for high vs. low quintile). Combined consumption of tomatoes, tomato sauce, tomato juice, and pizza was inversely associated with total prostate cancer (multivariate RR = 0.65; 95% CI, 0.44-0.95 for >10 vs. <1.5 servings/week) and advanced stages (multivariate RR = 0.47; 95% CI, 0.22-1.00).

Shows an association, not proof of cause and effect.

Giovannucci E, Ascherio A, Rimm EB, et al. J Natl Cancer Inst, 1995. PMID 7473833

1989 / Prospective cohort study

Consumption of tomatoes, legumes, and dried fruit was associated with significantly lower prostate cancer risk in Adventist men.

A cohort of approximately 14,000 Seventh-day Adventist men completed a lifestyle questionnaire in 1976 and were followed through 1982, during which 180 prostate cancer cases were detected. Increasing intake of beans, lentils and peas, tomatoes, raisins, dates, and other dried fruit were all linked to significantly decreased prostate cancer risk. A history of prostate trouble was associated with a highly significant 60% increase in risk. Suggestive links between animal product consumption and increased risk did not persist after accounting for fruit and vegetable intake, and childhood vegetarianism and BMI were not related to risk.

Shows an association, not proof of cause and effect.

Mills PK, Beeson WL, Phillips RL, et al. Cancer, 1989. PMID 2743254

2019 / Narrative review

Nutraceuticals, medicinal plants, and antioxidant-rich diets show potential roles in managing or preventing benign and malignant prostate diseases.

This review summarizes evidence for nutraceuticals and medicinal plants in treating and preventing prostate diseases. Epidemiological studies link the Mediterranean diet, high fruit and vegetable consumption, lycopene, and zinc with protection against prostate cancer or benign prostatic hyperplasia (BPH). Meta-analyses indicate Serenoa repens is more effective than placebo for mild to moderate lower urinary tract symptoms, while agents like lycopene, selenium, pollen extract, and beta-sitosterol also demonstrate symptomatic improvements in BPH or chronic pelvic pain syndrome.

Cicero AFG, Allkanjari O, Busetto GM, et al. Arch Ital Urol Androl, 2019. PMID 31577095

2007 / Evidence-based regulatory review

FDA found no credible evidence for lycopene and cancer reduction, and only very limited evidence linking tomato intake to reduced risks of four cancers.

The U.S. FDA evaluated scientific evidence submitted in petitions for qualified health claims regarding tomato and lycopene consumption and cancer risk. The agency found no credible evidence to support an association between lycopene intake and reduced risk of prostate, lung, colorectal, gastric, breast, ovarian, endometrial, or pancreatic cancer. Additionally, no credible evidence supported an association between tomato consumption and reduced risk of lung, colorectal, breast, cervical, or endometrial cancer. The FDA identified only very limited evidence supporting an association between tomato consumption and reduced risks of prostate, ovarian, gastric, and pancreatic cancers.

Shows an association, not proof of cause and effect.

Kavanaugh CJ, Trumbo PR, Ellwood KC J Natl Cancer Inst, 2007. PMID 17623802